Adoption Momentum For Paradigm4’s UK Biobank Platform
Summary
Paradigm4’ s newly launched REVEAL™ Translational Informatics Platform with its PheGe™ Browser enables bioinformaticians and scientists to readily work with the scale and diversity of public and proprietary multi-omics, behavioral, clinical, health outcomes, and environmental data generated today.“The absolute scale and diversity of the data in the UK Biobank will drive transformational GWAS/PheWAS research,” said Paradigm4’s CEO Marilyn Matz.“Our aggressive timelines provide biopharma customers with best-in-class performance and services to rapidly mine this valuable data set.”“The UK Biobank dataset redefines our view of Real World Evidence to support active clinical development projects where new insights into cohort selection for recruiting or stratifying patients are very valuable,” added Zachary Pitluk, Ph.D., V.P.The company was founded by renowned database researcher, Turing Award laureate MIT Professor Michael Stonebraker .